Bloomios, Inc. (BLMS)

Market Cap	20.36K +200.0%
Revenue (ttm)	8.23M +46.5%
Net Income	-39.61M
EPS	-1.76
Shares Out	67.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,000
Open	0.0003
Previous Close	n/a
Day's Range	0.0003 - 0.0003
52-Week Range	0.0001 - 0.0003
Beta	-0.45
Analysts	n/a
Price Target	n/a
Earnings Date	May 1, 2026

About Bloomios

Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company’s product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: BLMS

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 25, 2026

Data Sources Report a data error